rofecoxib has been researched along with Glomerulonephritis, IGA in 1 studies
Glomerulonephritis, IGA: A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, Q | 1 |
| Pestka, JJ | 1 |
1 other study available for rofecoxib and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Role of cyclooxygenase-2 in deoxynivalenol-induced immunoglobulin a nephropathy.
Topics: Analysis of Variance; Animals; Body Weight; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxyg | 2005 |